Pharmacological treatment of reflex syncope
- PMID: 15480933
- DOI: 10.1007/s10286-004-1010-4
Pharmacological treatment of reflex syncope
Abstract
Patient education, identification of possible triggers of syncope and reassurance are a central feature of the management of patients with reflex syncope. Patients should be advised as to the importance of adequate hydration and taught physical countermaneuvers to enhance cardiac venous return. These maneuvers are sufficient for most patients, however, for a small number of patients who continue to have recurrent syncopal events, pharmacological intervention may be considered. Volume expansion can be enhanced with salt and fludrocortisone. Agents from diverse pharmacological classes have been used to attenuate the reflex response, enhance vasoconstriction and attenuate vagal outflow. Alpha adrenoreceptor agonists, anticholinergic agents, theophylline, beta adrenoreceptor antagonists, serotonin reuptake inhibitors and disopyramide are the most widely studied. None of these agents has shown a consistent therapeutic benefit in clinical trials.
Similar articles
-
Strategy for the management of vasovagal syncope.Drugs Aging. 2002;19(3):179-202. doi: 10.2165/00002512-200219030-00003. Drugs Aging. 2002. PMID: 12027777 Review.
-
Medical therapy of neurocardiogenic syncope.Cardiol Clin. 2001 May;19(2):203-13, v. doi: 10.1016/s0733-8651(05)70208-3. Cardiol Clin. 2001. PMID: 11407106 Review.
-
Syncope in athletes: a guide to getting them back on their feet.J Fam Pract. 2007 Jul;56(7):545-50. J Fam Pract. 2007. PMID: 17605946 Review. No abstract available.
-
Oral disopyramide in the treatment of recurrent neurocardiogenic syncope.Int J Clin Pract. 1997 Jul-Aug;51(5):342. Int J Clin Pract. 1997. PMID: 9489103
-
Management of vasovagal syncope.J Cardiovasc Electrophysiol. 1999 Jun;10(6):874-86. doi: 10.1111/j.1540-8167.1999.tb00270.x. J Cardiovasc Electrophysiol. 1999. PMID: 10376927
Cited by
-
The effects of a novel "fluid loading" strategy on cardiovascular and haematological responses to orthostatic stress.Eur J Appl Physiol. 2009 Apr;105(6):899-908. doi: 10.1007/s00421-008-0976-3. Epub 2009 Jan 14. Eur J Appl Physiol. 2009. PMID: 19142656 Clinical Trial.
-
Baseline heart rate variability in children and adolescents with vasovagal syncope.Korean J Pediatr. 2014 Apr;57(4):193-8. doi: 10.3345/kjp.2014.57.4.193. Korean J Pediatr. 2014. PMID: 24868217 Free PMC article.
-
Increased hydration alone does not improve orthostatic tolerance in patients with neurocardiogenic syncope.Clin Auton Res. 2007 Apr;17(2):99-105. doi: 10.1007/s10286-007-0409-0. Epub 2007 Apr 25. Clin Auton Res. 2007. PMID: 17464552 Clinical Trial.
-
Drugs and pacemakers for vasovagal, carotid sinus and situational syncope.Cochrane Database Syst Rev. 2011 Oct 5;2011(10):CD004194. doi: 10.1002/14651858.CD004194.pub3. Cochrane Database Syst Rev. 2011. PMID: 21975744 Free PMC article.
-
Blood pressure regulation X: what happens when the muscle pump is lost? Post-exercise hypotension and syncope.Eur J Appl Physiol. 2014 Mar;114(3):561-78. doi: 10.1007/s00421-013-2761-1. Epub 2013 Nov 7. Eur J Appl Physiol. 2014. PMID: 24197081 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources